automated-microbiology-market

Global Automated Microbiology Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2024

14 Mar 2016 Format PDF icon PPT icon XLS icon Request Sample

The global automated microbiology market is predicted to expand during the estimated period due to growing occurrence of pathogen induced ailments. In current years, detection of pathogens with the help of the automated microbiology has created large thrust, as it assists in early recognition of different infectious agents like fungus, parasite, virus, viroid, bacterium and prion. These agents are the cause of severe ailments like Chickenpox, Rubella, Mumps, Ebola, Smallpox and Influenza.

Automated microbiology is the modern microbiology method that permits microbiologists to do the microbiology checks rapidly and perfectly. This method is an enhanced method for isolation, early discovery, measurement and classification of microorganisms and their products in medical sector , food sector and ecological sector. These methods offer different experimental approaches like sequencing and synthesis to change a biological system.

The primary aim of using automatic microbiology techniques is to create and know the human ailments like cancer & inherited diseases. These techniques also recognize new molecular targets for drug discovery. Further, the modernization in the automated microbiology method decreases the turnaround time, increases quality control and enhances the precision of the microbial tests.

The automated microbiology market sector has acquired significance due to new diseases outbreaks owing to mutation and adaption of bacteria. Automated microbiology has the capability of quickly responding to the growing demand of public by providing them with perfect best and fast recognition of the ailments and causal pathogens. Fast technical advancements in these methods are also contributing towards the growth and expansion of the worldwide automated microbiology market. In comparison to other microbial detecting systems, this method of automated microbiology has other added benefits like easy access and early detection. Thus, these kinds of new innovations attract new customers and drives the growth of the global automated microbiology market.

Further there are wide areas of applications in healthcare , power , energy and environment that further drives the uptake & growth of the automated microbiology methods. This contributes towards the growth and expansion of the automated microbiology market worldwide. But, the strict regulatory needs for using of microbiology items inhibits the growth of the market. Further, high prices of automated microbiology check methods also hinders the business & industrial growth of the automated microbiology in future.

The worldwide automated microbiology market is segmented on the basis of diagnostic techniques, end users and geographical regions.

The worldwide automated microbiology market by diagnostic techniques includes DNA Sequencing, Detection techniques, Monoclonal Antibodies, Immunoassays, DNA and RNA probe technology. Detection techniques includes non isotopic techniques and radioactive techniques. DNA and RNA probe technology includes amplification methods and labeling methods.

The monoclonal antibodies section contributed biggest market share in year 2014 due to their wide use to create the parent cell clone used in detecting infected cell or ailment.

The global automated microbiology market by end users includes blood banks, biotechnological industries, hospitals and clinical labs. Among this, clinical labs section accounted for biggest market share in year 2014. The key aspect contributing towards the growth and domination of this section is the comparatively big number of microbiological researches carried out at these clinical labs for detecting different contagious agents.

 The worldwide automated microbiology market by geographical regions includes sub continent of North America, continent of Europe, Asia Pacific region and region of the rest of the world.

The sub continent of North America leads the global automated microbiology market. The growth is primarily credited to the large scale presence of key market players that provide wide portfolio of automated microbiology. This sub continent dominated the industry in year 2014 due to high utilization of modern technology and introduction of modern molecular diagnostic tests like genetic probe.

The automated microbiology market of Europe follows North America . Introduction of modern molecular diagnostics checks like genetic probe tests are anticipated to propel the growth and expansion of the automated microbiology market in this continent. Further, favorable government policies and positive initiatives taken by the respective governments of the countries in Europe are projected to enhance the number of end users of this market sector.

The Asia Pacific region is predicted to observe a profitable market growth and expansion owing to rapid growth & improvement in healthcare infrastructure as well as improvement in healthcare facilities & healthcare services in this region. Also, increasing demand for technically advanced items in the region of Asia Pacific is predicted to further enhance the expansion of the automated microbiology market in the region of Asia Pacific. In addition to this, factors like growing demand for the automated microbiology techniques in countries like India and China of this region , heavy capital investments made by the governments of this region in the healthcare infrastructure & health care services and different initiatives taken by the state authorities to enhance the healthcare services & healthcare infrastructure has provided an impetus for the growth and development of the automated microbiology business in the region of Asia Pacific.

The key industry players included in this market report are as follows:

  • Beckman Coulter
  • Abbott Laboratories
  • Agilent Technologies Incorporation
  • Bio-Rad Laboratories Incorporation
  • Affymetrix Incorporation
  • BioMerieux Incorporation
  • QIAGEN GmbH
  • Becton Dickinson and Company
  • Gene-Probe Incorporation
Choose Licence Type
$4325
$6325
$8325
Why Acute
View Other Reports